Disclosed herein is a compound represented by Structural Formula (I):
1
R
1
is a substituted or unsubstituted aryl group or alkyl group; R
2
is a substituted or unsubstituted aryl group or cycloalkyl group; Ar is a substituted or unsubstituted aryl group; X is a —CH
2
—, —O—, —S— or —CO—; m is an integer from zero to two; n is an integer from 0-2 when X is —O—, —S— and 1-2 when X is —CH
2
— or —CO—.
Also disclosed are methods of inhibiting kallikrein activity or urokinase activity in subject in need of such inhibition by administering a compound represented by Structural Formula (I).
本文披露了一种由结构式(I)表示的化合物:1R1是取代或未取代的芳基或烷基;R2是取代或未取代的芳基或环烷基;Ar是取代或未取代的芳基;X是—
CH2—、—O—、—S—或—CO—;m是从零到二的整数;当X为—O—、—S—时,n是0-2,当X为— —或—CO—时,n为1-2。还披露了通过给需要抑制卡利克雷因活性或
尿激酶活性的受体以结构式(I)表示的化合物来抑制其活性的方法。